oral herpes


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
Related to oral herpes: canker sore, Oral thrush, angular cheilitis

oral herpes

References in periodicals archive ?
Does having oral herpes protect me from genital herpes?
Some experts have speculated that having oral herpes reduces the chances of acquiring genital herpes, but most authorities believe there is no significant cross-protection between the two types.
The vaccine didn't protect men, regardless of whether they had oral herpes.
The report includes a compilation of marketed and currently active projects in development of vaccines, antibodies and small molecules targeting herpes simplex virus type 1 or type 2 (HSV-1 or HSV-2) and varicella zoster virus (VZV) or human herpes virus type 3 (HHV-3) for prophylaxis and treatment of oral herpes, genital herpes, chickenpox (varicella) and herpes zoster, respectively.
The former funds, raised exclusively from private investors, are to be used to further the Company's two Phase 2 IND clinical trials currently in progress for influenza and recurrent oral herpes.
announced today that it has initiated a Phase 1/2a clinical evaluation of its novel therapeutic agent for treating recurrent oral herpes infections.
According to WHO and CDC statistics, over 80 percent of the population have oral herpes with about 20 percent of these expressing symptoms.
announced today that the FDA has approved its IND for a Phase 1/2a clinical evaluation of BTL-TML-HSV, a novel therapeutic agent for treating recurrent oral herpes infections.
Despite high unmet need, the market for the small molecules used to manage conditions such as genital and oral herpes, genital warts, cytomegalovirus retinitis and pneumonia or shingles has been neglected compared with the successfully promoted immunizations for varicella in children, zoster in adults, or human papilloma virus in adolescents.
In addition, two other innovative products are currently in Phase III clinical trials: acyclovir Lauriad[R] in oral herpes (based on the same Lauriad[R] muco-adhesive technology as Loramyc[R], which enables targeted release at the disease site) and doxorubicin Transdrug[R] in primary liver cancer (based on the Transdrug[R] nanoparticle technology, designed specifically for intracellular targeting of resistant cells).